Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19861655

High-quality remission : potential benefits of the melatonergic approach for patients with major depressive disorder

Author
LAM, Raymond W1
[1] Division of Clinical Neuroscience, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Conference title
Paving the way to remission: the melatonergic approach in depression
Conference name
Paving the way to remission: the melatonergic approach in depression. Satellite symposium (Vienna 2007-10-15)
Author (monograph)
KASPER, Siegfried (Editor)1 ; MONTGOMERY, Stuart A (Editor)2
[1] Department of General Psychiatry, Medical University of Vienna, Austria
[2] Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich, Germany
Source

International clinical psychopharmacology. 2007, Vol 22 ; S21-S25 ; SUP2 ; ref : 1 p

ISSN
0268-1315
Scientific domain
Pharmacology drugs; Psychology, psychopathology, psychiatry
Publisher
Lippincott Williams & Wilkins, Hagerstown, MD
Publication country
United States
Document type
Conference Paper
Language
English
Author keyword
agomelatine antidepressant major depressive disorder relapse remission residual symptoms
Keyword (fr)
Agomélatine Antidépresseur Chimiothérapie Etat dépressif Homme Psychotrope Récepteur mélatonine Récepteur sérotoninergique 5-HT2A Récidive Rémission Symptomatologie Analogue Hormone épiphysaire Mélatonine Traitement Trouble de l'humeur
Keyword (en)
Agomelatine Antidepressant agent Chemotherapy Depression Human Psychotropic Melatonin receptor 5-HT2A serotonin receptor Relapse Remission Symptomatology Analog Pineal hormone Melatonin Treatment Mood disorder
Keyword (es)
Agomelatina Antidepresor Quimioterapia Estado depresivo Hombre Psicotropo Receptor melatonina Receptor serotoninérgico 5-HT2A Recaida Remisión Sintomatología Análogo Hormona epifisaria Melatonina Tratamiento Trastorno humor
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07A Depression

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G01 Depression

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
19861655

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web